Korro Bio, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: KRRO
Korro Bio, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker KRRO. It has reported private securities offerings to the US SEC, most recently $42 million sold in a notice filed in 2020.
What does Korro Bio do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $42.3 million sold (2020).
Frequently asked questions about Korro Bio
Where is Korro Bio headquartered?
Korro Bio, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Korro Bio do?
Korro Bio, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Korro Bio a public company?
Yes. Korro Bio, Inc. trades on Nasdaq under the ticker KRRO.
When was Korro Bio founded?
The earliest incorporation on record for Korro Bio, Inc. is in 2014, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.